Cantor Fitzgerald analyst Brett Knoblauch reiterated an Overweight rating on Strategy (NASDAQ: MSTR).The analyst commented, "Strategy (MSTR, OW) purchased 1,550 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments